Nuvalent • NUVL
Nuvalent Inc is a clinical stage biopharmaceutical company focused on creating precisely targeted therapies for patients with cancer.
Ratings
0 / 5
0 ratings in the last 12 months
5
4
3
2
1
CEO
Dr. James R. Porter, PhD$4.2B
Market Cap • 25/04/20242017
(há 7 anos)
2021
(3 years ago)
NASDAQ
Listagem
Cambridge
Sede • Massachusetts62
N° de Empregados • 2022Valuation
Company FinancialsValuation Indicators
Valuation IndicatorsRetorno Histórico
NUVLSó no Premium...
Visualize o retorno de longo prazo das ações. Dividendos e outros eventos são considerados.